Table 3

Summary of glucose metrics according to treatment group

Treatment group
Intensive (n = 711)Conventional (n = 729)
% TIR 52 ± 10 31 ± 12 
Mean glucose (mg/dL) 160 ± 30 233 ± 47 
% Time >180 mg/dL 34 ± 12 64 ± 15 
% Time >250 mg/dL 13 (8, 20) 41 (30, 53) 
AUC 180 mg/dL 23 (15, 35) 71 (49, 97) 
HBGI 8 (6, 11) 21 (16, 27) 
A1C (%) 7.3 ± 1.0 9.1 ± 1.3 
% Time <70 mg/dL 13 (9, 17) 5 (2, 8) 
% Time <54 mg/dL 5 (3, 7) 2 (1, 3) 
Coefficient of variation (%) 53 ± 7 46 ± 7 
Treatment group
Intensive (n = 711)Conventional (n = 729)
% TIR 52 ± 10 31 ± 12 
Mean glucose (mg/dL) 160 ± 30 233 ± 47 
% Time >180 mg/dL 34 ± 12 64 ± 15 
% Time >250 mg/dL 13 (8, 20) 41 (30, 53) 
AUC 180 mg/dL 23 (15, 35) 71 (49, 97) 
HBGI 8 (6, 11) 21 (16, 27) 
A1C (%) 7.3 ± 1.0 9.1 ± 1.3 
% Time <70 mg/dL 13 (9, 17) 5 (2, 8) 
% Time <54 mg/dL 5 (3, 7) 2 (1, 3) 
Coefficient of variation (%) 53 ± 7 46 ± 7 

Values shown are mean ± SD or median (quartiles) as appropriate for the distribution. For treatment group comparison of each metric, P value <0.001 from a linear regression model adjusted for the baseline value. Due to skewed distributions, van der Waerden scores were used for % time >250 mg/dL, AUC 180 mg/dL, HBGI, % time <70 mg/dL, and % time <54 mg/dL. AUC, area under the curve; HBGI, high blood glucose index.

Close Modal

or Create an Account

Close Modal
Close Modal